Cargando…
Infectious Complications of Targeted Therapies in Children with Leukemias and Lymphomas
SIMPLE SUMMARY: Targeted therapies in children with hematological malignancies moderate the effects of cytotoxic therapy, thus improving survival rates. They have emerged over the last decade and are used in combination with or after the failure of conventional chemotherapy and as bridging therapy p...
Autores principales: | Kyriakidis, Ioannis, Mantadakis, Elpis, Stiakaki, Eftichia, Groll, Andreas H., Tragiannidis, Athanasios |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9599435/ https://www.ncbi.nlm.nih.gov/pubmed/36291806 http://dx.doi.org/10.3390/cancers14205022 |
Ejemplares similares
-
Invasive Fungal Diseases in Children with Hematological Malignancies Treated with Therapies That Target Cell Surface Antigens: Monoclonal Antibodies, Immune Checkpoint Inhibitors and CAR T-Cell Therapies
por: Kyriakidis, Ioannis, et al.
Publicado: (2021) -
Extrahepatic Biliary Atresia, Liver Function Tests, and Hemoglobin Variants
por: Kyriakidis, Ioannis, et al.
Publicado: (2018) -
Pneumocystis jirovecii Pneumonia in Children with Hematological Malignancies: Diagnosis and Approaches to Management
por: Mantadakis, Elpis
Publicado: (2020) -
Infectious Complications of Targeted Therapies for Solid Cancers or Leukemias/Lymphomas
por: Pilmis, Benoît, et al.
Publicado: (2023) -
Enhanced levels of the apoptotic BAX/BCL-2 ratio in children with acute lymphoblastic leukemia and high-risk features
por: Kaparou, Maria, et al.
Publicado: (2013)